HGH Biosimilars Market Report

China HGH Biosimilars Industry Market Research Report 2023-2029

  • POSTDATE：Oct 14, 2023
  • PAGES：213
  • REPORT CODE：GMM1852689
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.

    The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and OthersCompany profiles are primarily based on public domain information including companyJohnson & JohnsonGilead SciencesPaciraSun PharmaceuticalLuye PharmaSigma-Tau GroupFudan-ZhangjiangTeva PharmaceuticalCSPCNovartisKingond Pharm

    This report elaborates on the current development of the HGH Biosimilars industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis

    • Sigma-Tau Group

    • Gilead Sciences

    • Pacira

    • Luye Pharma

    • Johnson & Johnson

    • Fudan-Zhangjiang

    • Sun Pharmaceutical

    • Teva Pharmaceutical

    By Type:

    • Clinical

    • Experiment

    By Application:

    • Prevention

    • Treament

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China HGH Biosimilars Market Overview 2018-2029

    • 1.1 China HGH Biosimilars Industry Development Overview

    • 1.2 China HGH Biosimilars Industry Development History

    • 1.3 China HGH Biosimilars Industry Market Size (2018-2029)

    • 1.4 China HGH Biosimilars Market Analysis by Type from Production Side

      • 1.4.1 China HGH Biosimilars Production Volume, Production Value and Growth Rate of Clinical (2018-2029)

      • 1.4.2 China HGH Biosimilars Production Volume, Production Value and Growth Rate of Experiment (2018-2029)

    • 1.5 China HGH Biosimilars Market Analysis by Application from Consumption End

      • 1.5.1 China HGH Biosimilars Sales Volume, Sales Value and Growth Rate of Prevention (2018-2029)

      • 1.5.2 China HGH Biosimilars Sales Volume, Sales Value and Growth Rate of Treament (2018-2029)

    • 1.6 China HGH Biosimilars Market Analysis by Region

      • 1.6.1 North China HGH Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China HGH Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China HGH Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China HGH Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China HGH Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China HGH Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    Chapter 2 China HGH Biosimilars Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on HGH Biosimilars Market Status and Competition at home and abroad in 2023

      • 2.2.2 China HGH Biosimilars Market Status and Competition Analysis in 2023

      • 2.2.3 China HGH Biosimilars Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China HGH Biosimilars Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on HGH Biosimilars Industry Development

    Chapter 3 HGH BiosimilarsIndustry Chain Analysis

    • 3.1 HGH Biosimilars Industry Chain

    • 3.2 HGH Biosimilars Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the HGH Biosimilars Market

    • 3.3 HGH Biosimilars Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the HGH Biosimilars Market

    Chapter 4 China HGH Biosimilars Market, by Type

    • 4.1 China HGH Biosimilars Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China HGH Biosimilars Total Production Volume and Growth Rate from Production Side

    • 4.5 China HGH Biosimilars Production Volume and Growth Rate, by Type

      • 4.5.1 China HGH Biosimilars Production Volume and Growth Rate of Clinical

      • 4.5.2 China HGH Biosimilars Production Volume and Growth Rate of Experiment

    Chapter 5 China HGH Biosimilars Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China HGH Biosimilars Total Market Size and Growth Rate from Consumption End

    • 5.5 China HGH Biosimilars Market Size and Growth Rate, by Application

      • 5.5.1 China HGH Biosimilars Market Size and Growth Rate of Prevention

      • 5.5.2 China HGH Biosimilars Market Size and Growth Rate of Treament

    Chapter 6 China HGH Biosimilars Market, by Region

    • 6.1 China HGH Biosimilars Production Volume and Production Value, by Region

    • 6.2 China HGH Biosimilars Sales Volume and Sales Value, by Region

    Chapter 7 North China HGH Biosimilars Market Analysis

    • 7.1 North China HGH Biosimilars Market, by Type

    • 7.2 North China HGH Biosimilars Market, by Application

    Chapter 8 Central China HGH Biosimilars Market Analysis

    • 8.1 Central China HGH Biosimilars Market, by Type

    • 8.2 Central China HGH Biosimilars Market, by Application

    Chapter 9 South China HGH Biosimilars Market Analysis

    • 9.1 South China HGH Biosimilars Market, by Type

    • 9.2 South China HGH Biosimilars Market, by Application

    Chapter 10 East China HGH Biosimilars Market Analysis

    • 10.1 East China HGH Biosimilars Market, by Type

    • 10.2 East China HGH Biosimilars Market, by Application

    Chapter 11 Northeast China HGH Biosimilars Market Analysis

    • 11.1 Northeast China HGH Biosimilars Market, by Type

    • 11.2 Northeast China HGH Biosimilars Market, by Application

    Chapter 12 Southwest China HGH Biosimilars Market Analysis

    • 12.1 Southwest China HGH Biosimilars Market, by Type

    • 12.2 Southwest China HGH Biosimilars Market, by Application

    Chapter 13 Northwest China HGH Biosimilars Market Analysis

    • 13.1 Northwest China HGH Biosimilars Market, by Type

    • 13.2 Northwest China HGH Biosimilars Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis

        • 14.1.1 Novartis Company Profile

        • 14.1.2 Novartis HGH Biosimilars Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sigma-Tau Group

        • 14.2.1 Sigma-Tau Group Company Profile

        • 14.2.2 Sigma-Tau Group HGH Biosimilars Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Gilead Sciences

        • 14.3.1 Gilead Sciences Company Profile

        • 14.3.2 Gilead Sciences HGH Biosimilars Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pacira

        • 14.4.1 Pacira Company Profile

        • 14.4.2 Pacira HGH Biosimilars Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Luye Pharma

        • 14.5.1 Luye Pharma Company Profile

        • 14.5.2 Luye Pharma HGH Biosimilars Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Johnson & Johnson

        • 14.6.1 Johnson & Johnson Company Profile

        • 14.6.2 Johnson & Johnson HGH Biosimilars Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Fudan-Zhangjiang

        • 14.7.1 Fudan-Zhangjiang Company Profile

        • 14.7.2 Fudan-Zhangjiang HGH Biosimilars Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Sun Pharmaceutical

        • 14.8.1 Sun Pharmaceutical Company Profile

        • 14.8.2 Sun Pharmaceutical HGH Biosimilars Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Teva Pharmaceutical

        • 14.9.1 Teva Pharmaceutical Company Profile

        • 14.9.2 Teva Pharmaceutical HGH Biosimilars Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 HGH Biosimilars Industry Research Conclusions

    • 15.2 HGH Biosimilars Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China HGH Biosimilars Industry Market Size (2018-2029)

    • Figure China HGH Biosimilars Production Volume, Production Value and Growth Rate of Clinical (2018-2029)

    • Figure China HGH Biosimilars Production Volume, Production Value and Growth Rate of Experiment (2018-2029)

    • Figure China HGH Biosimilars Sales Volume, Sales Value and Growth Rate of Prevention (2018-2029)

    • Figure China HGH Biosimilars Sales Volume, Sales Value and Growth Rate of Treament (2018-2029)

    • Figure North China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Central China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure South China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure East China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northeast China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Southwest China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northwest China HGH Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure HGH Biosimilars Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China HGH Biosimilars Market Share by Type in 2018

    • Figure China HGH Biosimilars Market Share by Type in 2023

    • Figure China HGH Biosimilars Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China HGH Biosimilars Production Volume and Growth Rate of Clinical (2018-2023)

    • Figure China HGH Biosimilars Production Volume and Growth Rate of Experiment (2018-2023)

    • Figure China HGH Biosimilars Market Share by Application in 2018

    • Figure China HGH Biosimilars Market Share by Application in 2023

    • Figure China HGH Biosimilars Total Market Size and Growth Rate from Consumption End

    • Figure China HGH Biosimilars Market Size and Growth Rate of Prevention (2018-2023)

    • Figure China HGH Biosimilars Market Size and Growth Rate of Treament (2018-2023)

    • Table China HGH Biosimilars Production Volume by Region (2018-2023)

    • Table China HGH Biosimilars Production Volume Share by Region (2018-2023)

    • Figure China HGH Biosimilars Production Volume Share by Region (2018-2023)

    • Table China HGH Biosimilars Production Value by Region (2018-2023)

    • Table China HGH Biosimilars Production Value Share by Region (2018-2023)

    • Figure China HGH Biosimilars Production Value Share by Region (2018-2023)

    • Table China HGH Biosimilars Sales Volume by Region (2018-2023)

    • Table China HGH Biosimilars Sales Volume Share by Region (2018-2023)

    • Figure China HGH Biosimilars Sales Volume Share by Region (2018-2023)

    • Table China HGH Biosimilars Sales Value by Region (2018-2023)

    • Table China HGH Biosimilars Sales Value Share by Region (2018-2023)

    • Figure China HGH Biosimilars Sales Value Share by Region (2018-2023)

    • Table North China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table North China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure North China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table North China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table North China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure North China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Central China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table Central China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Central China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table Central China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table Central China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Central China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table South China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table South China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure South China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table South China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table South China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure South China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table East China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table East China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure East China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table East China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table East China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure East China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northeast China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table Northeast China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northeast China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northeast China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table Northeast China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northeast China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Southwest China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table Southwest China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Southwest China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table Southwest China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table Southwest China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Southwest China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northwest China HGH Biosimilars Production Volume by Type (2018-2023)

    • Table Northwest China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northwest China HGH Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northwest China HGH Biosimilars Sales Volume by Application (2018-2023)

    • Table Northwest China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northwest China HGH Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Sigma-Tau Group Company Profile

    • Table Sigma-Tau Group HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Company Profile

    • Table Gilead Sciences HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Pacira Company Profile

    • Table Pacira HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Luye Pharma Company Profile

    • Table Luye Pharma HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Fudan-Zhangjiang Company Profile

    • Table Fudan-Zhangjiang HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Company Profile

    • Table Sun Pharmaceutical HGH Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical HGH Biosimilars Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US